INTERACTIONS OF DOXAZOSIN WITH INSULIN OR GLUCAGON IN THE OB/OB MOUSE

被引：2

作者：

SWINDELL, AC

VALENTINE, JJ

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1989年 / 13卷

关键词：

D O I：

10.1097/00005344-198900132-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S20 / S24

页数：5

共 25 条

[1] METABOLIC EFFECTS OF PRAZOSIN [J].

BARBIERI, C ;

CALDARA, R ;

FERRARI, C ;

DALBO, GA ;

PARACCHI, A ;

ROMUSSI, M ;

CURTARELLI, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :313-316

[2] METABOLIC EFFECTS OF CHRONIC PRAZOSIN TREATMENT [J].

BARBIERI, C ;

FERRARI, C ;

BORZIO, M ;

PIEPOLI, V ;

CALDARA, R .

HORMONE AND METABOLIC RESEARCH, 1980, 12 (07) :331-334

[3] HYPOTHALAMIC AND GENETIC OBESITY IN EXPERIMENTAL-ANIMALS - AUTONOMIC AND ENDOCRINE HYPOTHESIS [J].

BRAY, GA ;

YORK, DA .

PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :719-809

[4] SUPPRESSION OF TRIGLYCERIDE SECRETION BY EPINEPHRINE IN ISOLATED RAT HEPATOCYTES [J].

BRINDLE, NPJ ;

ONTKO, JA .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (01) :191-197

[5] THE ANTIHYPERTENSIVE EFFECTS OF DOXAZOSIN - A CLINICAL OVERVIEW [J].

COX, DA ;

LEADER, JP ;

MILSON, JA ;

SINGLETON, W .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S83-S90

[6] FROM GLYCOGEN TO KETONES - AND BACK [J].

FOSTER, DW .

DIABETES, 1984, 33 (12) :1188-1199

[7]

GRANNER DK, 1986, RECENT PROG HORM RES, V42, P111

[8]

JANSEN H, 1987, J CARDIOVASC PHARM, V10, pS16

[9]

KARNIELI E, 1981, J BIOL CHEM, V256, P4772

[10] MECHANISM OF ADRENERGIC-STIMULATION OF HEPATIC KETOGENESIS [J].

KOSUGI, K ;

HARANO, Y ;

NAKANO, T ;

SUZUKI, M ;

KASHIWAGI, A ;

SHIGETA, Y .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (11) :1081-1087

← 1 2 3 →